Edap Tms S.A. (NASDAQ:EDAP) Sees Significant Decline in Short Interest

Edap Tms S.A. (NASDAQ:EDAP) saw a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 75,567 shares, a drop of 20.6% from the January 15th total of 95,120 shares. Approximately 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 82,208 shares, the short-interest ratio is currently 0.9 days. Based on an average daily trading volume, of 82,208 shares, the short-interest ratio is currently 0.9 days. Approximately 0.2% of the shares of the stock are short sold.

Edap Tms Stock Down 2.1%

NASDAQ:EDAP traded down $0.10 on Monday, reaching $4.67. 64,178 shares of the stock traded hands, compared to its average volume of 90,642. The company has a current ratio of 1.41, a quick ratio of 0.97 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $174.61 million, a price-to-earnings ratio of -8.19 and a beta of -0.16. Edap Tms has a 12 month low of $1.21 and a 12 month high of $5.05. The company’s fifty day simple moving average is $3.65 and its 200 day simple moving average is $2.65.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Edap Tms in a research report on Monday, December 29th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $2.00 price target on shares of Edap Tms in a research note on Thursday, November 6th. Finally, Wall Street Zen raised Edap Tms to a “hold” rating in a research report on Saturday, February 7th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Edap Tms presently has a consensus rating of “Hold” and an average target price of $8.50.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Financial Planning Navigators CORP bought a new position in shares of Edap Tms in the 4th quarter worth approximately $33,000. Kovack Advisors Inc. purchased a new position in Edap Tms during the fourth quarter valued at $53,000. Sage Mountain Advisors LLC bought a new stake in Edap Tms during the second quarter valued at about $165,000. Finally, Leonteq Securities AG purchased a new stake in Edap Tms in the fourth quarter worth about $313,000. 62.74% of the stock is owned by hedge funds and other institutional investors.

About Edap Tms

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.